Literature DB >> 20409500

Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers.

Jeffrey H Coben1, Stephen M Davis, Paul M Furbee, Rosanna D Sikora, Roger D Tillotson, Robert M Bossarte.   

Abstract

BACKGROUND: Unintentional poisoning deaths have been increasing dramatically over the past decade, and the majority of this increase has resulted from overdoses of specific prescription drugs. Despite this trend, there are limited existing data examining hospitalizations for poisonings, both unintentional and intentional, associated with prescription drugs. A better understanding of these hospitalizations may help identify high-risk populations in need of intervention to prevent subsequent mortality.
PURPOSE: This article aims to describe the incidence and characteristics of hospitalizations resulting from poisoning by prescription opioids, sedatives, and tranquilizers in the U.S. from 1999 to 2006 and make comparisons to hospitalizations for all other poisonings during this time period.
METHODS: Hospitalizations for poisonings were selected from the Nationwide Inpatient Sample (NIS), a stratified, representative sample of approximately 8 million hospitalizations each year, according to the principal discharge diagnosis. Intentionality of the poisoning was determined by external cause of injury codes. SAS callable SUDAAN software was used to calculate weighted estimates of poisoning hospitalizations by type and intentionality. Demographic and clinical characteristics of poisoning cohorts were compared. Data were analyzed in 2009.
RESULTS: From 1999 to 2006, U.S. hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers increased a total of 65%. This increase was double the increase observed in hospitalizations for poisoning by other drugs and substances. The largest increase in the number of hospitalized cases over the 7-year period was seen for poisonings by benzodiazepines, whereas the largest percentage increase was observed for methadone (400%). In comparison to patients hospitalized for poisoning from other substances, those hospitalized for prescription opioids, sedatives, and tranquilizers were more likely to be women, aged >34 years, and to present to a rural or urban nonteaching hospital.
CONCLUSIONS: Prescription opioids, sedatives, and tranquilizers are an increasing cause of hospitalization. The hospital admission provides an opportunity to better understand the contextual factors contributing to these cases, which may aid in the development of targeted prevention strategies. 2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409500     DOI: 10.1016/j.amepre.2010.01.022

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  66 in total

1.  Assessment of Selected Overdose Poisoning Indicators in Health Care Administrative Data in 4 States, 2012.

Authors:  Beth Hume; Barbara Gabella; Jeanne Hathaway; Scott Proescholdbell; Cristy Sneddon; Elizabeth Brutsch; Riley Hedin; Christopher J Drucker
Journal:  Public Health Rep       Date:  2017-06-20       Impact factor: 2.792

2.  A response to the opioid overdose epidemic: naloxone nasal spray.

Authors:  Daniel P Wermeling
Journal:  Drug Deliv Transl Res       Date:  2013-02-01       Impact factor: 4.617

3.  Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001-12.

Authors:  Douglas J Hsu; Ellen P McCarthy; Jennifer P Stevens; Kenneth J Mukamal
Journal:  Addiction       Date:  2017-03-16       Impact factor: 6.526

Review 4.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

5.  The Roles of Emotion Regulation Difficulties and Impulsivity in the Associations between Borderline Personality Disorder Symptoms and Frequency of Nonprescription Sedative Use and Prescription Sedative/Opioid Misuse.

Authors:  Julia R Richmond; Matthew T Tull; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2020-03-16

6.  The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy.

Authors:  Michael Von Korff; Sascha Dublin; Rod L Walker; Michael Parchman; Susan M Shortreed; Ryan N Hansen; Kathleen Saunders
Journal:  J Pain       Date:  2015-10-22       Impact factor: 5.820

7.  Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial.

Authors:  D Max Crowley; Damon E Jones; Donna L Coffman; Mark T Greenberg
Journal:  Prev Med       Date:  2014-02-09       Impact factor: 4.018

8.  Infant and Youth Mortality Trends by Race/Ethnicity and Cause of Death in the United States.

Authors:  Sahar Q Khan; Amy Berrington de Gonzalez; Ana F Best; Yingxi Chen; Emily A Haozous; Erik J Rodriquez; Susan Spillane; David A Thomas; Diana Withrow; Neal D Freedman; Meredith S Shiels
Journal:  JAMA Pediatr       Date:  2018-12-03       Impact factor: 16.193

Review 9.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

Review 10.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.